Sun Pharma Advanced Research Company Limited Asset Resilience Ratio

Latest as of September 2025: 0.64%

Sun Pharma Advanced Research Company Limited asset resilience ratio. Sun Pharma Advanced Research Company Limited (SPARC) has an Asset Resilience Ratio of 0.64% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Sun Pharma Advanced Research Company Lim fund operations to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs20.60 Million

≈ $222.78K USD Cash + Short-term Investments

Total Assets

Rs3.22 Billion

≈ $34.87 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Sun Pharma Advanced Research Company Limited (2013–2025)

Asset resilience ratio of Sun Pharma Advanced Research Company Limited from 2013 to 2025. This chart shows how Sun Pharma Advanced Research Company Limited's Asset Resilience Ratio has changed over time. Read SPARC current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Sun Pharma Advanced Research Company Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SPARC total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs20.60 Million	0.64%
Total Liquid Assets	Rs20.60 Million	0.64%

Asset Resilience Insights

Limited Liquidity: Sun Pharma Advanced Research Company Limited maintains only 0.64% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Sun Pharma Advanced Research Company Limited Industry Peers by Asset Resilience Ratio

Compare Sun Pharma Advanced Research Company Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Sun Pharma Advanced Research Company Limited Asset Resilience Ratio by Year (2013–2025)

Sun Pharma Advanced Research Company Limited asset resilience ratio by year from 2013 to 2025. The table below shows the annual Asset Resilience Ratio data for Sun Pharma Advanced Research Company Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.70%	Rs23.60 Million ≈ $255.23K	Rs3.36 Billion ≈ $36.29 Million	-28.77pp
2024-03-31	29.47%	Rs1.52 Billion ≈ $16.42 Million	Rs5.15 Billion ≈ $55.70 Million	-32.31pp
2023-03-31	61.78%	Rs5.13 Billion ≈ $55.47 Million	Rs8.30 Billion ≈ $89.77 Million	+57.62pp
2022-03-31	4.16%	Rs116.65 Million ≈ $1.26 Million	Rs2.80 Billion ≈ $30.29 Million	+1.37pp
2021-03-31	2.80%	Rs64.25 Million ≈ $694.86K	Rs2.30 Billion ≈ $24.84 Million	-0.32pp
2020-03-31	3.12%	Rs84.91 Million ≈ $918.26K	Rs2.73 Billion ≈ $29.48 Million	-49.73pp
2019-03-31	52.85%	Rs2.11 Billion ≈ $22.77 Million	Rs3.98 Billion ≈ $43.09 Million	+17.22pp
2018-03-31	35.62%	Rs1.10 Billion ≈ $11.90 Million	Rs3.09 Billion ≈ $33.40 Million	+6.48pp
2017-03-31	29.14%	Rs798.60 Million ≈ $8.64 Million	Rs2.74 Billion ≈ $29.64 Million	+25.60pp
2014-03-31	3.54%	Rs65.00 Million ≈ $702.97K	Rs1.84 Billion ≈ $19.85 Million	-42.83pp
2013-03-31	46.37%	Rs969.06 Million ≈ $10.48 Million	Rs2.09 Billion ≈ $22.60 Million	--

pp = percentage points

About Sun Pharma Advanced Research Company Limited

NSE:SPARC India Drug Manufacturers - Specialty & Generic

Market Cap

$650.43 Million

Rs60.14 Billion INR

Market Cap Rank

#10643 Global

#536 in India

Share Price

Rs185.33

Change (1 day)

+5.46%

52-Week Range

Rs108.71 - Rs277.57

All Time High

Rs519.35